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Abstract
 
Caspase activation is a central event in numerous forms of apoptosis and results in the pro-
teolytic degradation of multiple substrate proteins that contribute to the apoptotic phenotype.
An important route to caspase activation proceeds via assembly of the “apoptosome” as a result
of the cell stress–associated release of mitochondrial cytochrome 
 
c
 
. Previous studies have shown
that primary neutrophils are largely incapable of mitochondrial respiration, suggesting that these
cells either lack functional mitochondria or possess a defective respiratory chain. This prompted
us to examine whether neutrophils retain an intact cytochrome 
 
c
 
/apoptotic protease-activating
factor 1 (Apaf-1) pathway to caspase activation and apoptosis. We show that primary human
neutrophils contain barely detectable levels of cytochrome 
 
c 
 
as well as other mitochondrial pro-
teins. Surprisingly, neutrophil cell–free extracts readily supported Apaf-1–dependent caspase ac-
tivation, suggesting that these cells may assemble cytochrome 
 
c
 
–independent apoptosomes.
However, further analysis revealed that the trace amount of cytochrome 
 
c
 
 present in neutrophils
is both necessary and sufficient for Apaf-1–dependent caspase activation in these cells. Thus,
neutrophils have a lowered threshold requirement for cytochrome 
 
c
 
 in the Apaf-1–dependent
cell death pathway. These observations suggest that neutrophils retain cytochrome 
 
c
 
 for the pur-
pose of assembling functional apoptosomes rather than for oxidative phosphorylation.
Key words: apoptosis • XIAP • caspases • cytochrome 
 
c
 
 • neutrophil
 
Introduction
 
Neutrophils are granulocytes that have relatively short
lifespans of 18–24 h and therefore undergo constant turn-
over in vivo. It is well established that senescent neutro-
phils undergo caspase-dependent apoptosis that can be in-
hibited by cytokines or proinflammatory stimuli, thereby
prolonging the function of these cells at inflammatory sites
(1–3). However, neutrophil apoptosis remains relatively
poorly defined at a molecular level and the trigger for se-
nescence-associated neutrophil apoptosis remains to be es-
tablished. Much of what we know concerning the molecu-
lar control of apoptosis is derived from studies on
transformed or proliferating cells. However, it remains un-
clear whether the well-established pathways to apoptosis
are accessible in all cells or whether cell type–specific path-
ways exist. For example, although specific caspases have
been established to act as initiators of apoptosis in many sit-
uations, it is not clear whether the caspase repertoire differs
substantially between distinct cell types. The absence of
certain initiator caspases or other key components of the
cell death machinery may render certain cell death path-
ways inaccessible in some cell types.
Caspases are cysteine proteases that play an evolutionary
conserved role in apoptosis from nematodes to man (4–7).
Three major routes to caspase activation and apoptosis have
been defined at present. One route, the death receptor
pathway, is initiated through interactions between certain
cytokines of the TNF/nerve growth factor superfamily and
their cognate receptors (e.g., TNFR, CD95R, and TNF-
related apoptosis-inducing ligand receptor). Upon engage-
ment, the latter receptors recruit adaptor molecules, such
as TNF receptor type I–associated death domain and Fas-
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associated protein with a death domain, which can directly
bind to specific caspases and promote their activation (8, 9).
The second major pathway to caspase activation is more re-
cently described and is triggered by the release of mito-
chondrial cytochrome 
 
c
 
 into the cytosol in response to cel-
lular damage or stress (10–12). Diverse cytotoxic drugs, as
well as radiation and heat shock, can engage the latter path-
way. Upon entry into the cytosol, cytochrome 
 
c
 
 interacts
with apoptotic protease-activating factor 1 (Apaf-1),
 
*
 
which promotes oligomerization of the latter and permits
recruitment of caspase-9 molecules into the complex (13).
Recruitment of several caspase-9 molecules into the Apaf-1
apoptosome permits autoprocessing and activation of this
caspase that can then process additional caspases down-
stream (14). In the third major pathway to caspase activa-
tion, CTL/NK cells can engage the cell death machinery
through direct proteolytic processing of caspases via the
CTL/NK granule component, granzyme B (15, 16).
It is well established that neutrophils, as well as other
granulocytes, are capable of engaging the death receptor
pathway to apoptosis (17, 18). In addition, many cytotoxic
drugs that are considered to engage the mitochondrial apop-
tosome pathway also promote neutrophil apoptosis, sug-
gesting that this pathway is also intact in these cells (19).
However, the presence of functional mitochondria in neu-
trophils has been the subject of debate. Recent reports in-
dicate that primary human neutrophils are essentially inca-
pable of oxidative phosphorylation, suggesting that these
cells contain few mitochondria or that neutrophils may lack
key respiratory chain components (20). Mitochondrial-like
structures have been observed in neutrophils and other
granulocytes using fluorescent dyes that preferentially label
mitochondria (21, 22). However, these structures tend to
be relatively few in number and have not been confirmed
to contain cytochrome 
 
c
 
 or other proteins that participate
in the regulation of apoptosis.
Because of the importance of the mitochondrion as a
conduit for numerous death-promoting stimuli, we were
prompted to explore whether neutrophils retained an intact
mitochondrial apoptosome pathway to apoptosis. Here, we
report that primary human neutrophils contain very mini-
mal amounts of cytochrome 
 
c 
 
compared with many trans-
formed cell lines, but that these levels were still sufficient to
engage the apoptosome pathway to caspase activation. In
line with this observation, neutrophil apoptosomes became
active at much lower cytochrome 
 
c
 
 concentrations than
were required to initiate caspase activation in other cell
types. Thus, neutrophils have a lowered threshold require-
ment for engagement of the Apaf-1 pathway by cyto-
chrome 
 
c
 
. These observations suggest that neutrophils re-
tain cytochrome 
 
c
 
 for the purpose of assembling functional
apoptosomes rather than for mitochondrial respiration.
 
Materials and Methods
 
Reagents.
 
Anti–cytochrome 
 
c
 
, anti–caspase-2, anti–caspase-3,
anti–caspase-7, anti–X-linked inhibitor of apoptosis protein
(XIAP), anti-BRUCE, and anti-gelsolin antibodies were pur-
chased from BD Biosciences; anti–caspase-1 rabbit polyclonal an-
tibody was purchased from Santa Cruz Biotechnology, Inc.; anti–
caspase-6 and anti–caspase-9 antibodies were purchased from
Upstate Biotechnology; anti–cIAP-1 and anti-survivin antibodies
were from R&D Systems; anti–manganese superoxidase dismu-
tase and anti–heat shock protein 60 (HSP-60) antibodies were
from StressGen Biotechnologies; anti–caspase-9 antibodies were
purchased from Oncogene Research Products; anti–caspase-8
mAb was provided by M. Peter (Ben May Institute for Cancer
Research, Chicago, IL); anti–cytochrome 
 
c 
 
oxidase, subunit I,
was purchased from Molecular Probes; second mitochondrial ac-
tivator of caspases (Smac) polyclonal antibody was generated by
immunizing rabbits with recombinant polyhistidine-tagged Smac
and has been described previously (23); antibodies selectively rec-
ognizing active caspase-3 were purchased from New England Bi-
olabs, Inc.; and anti-actin and anti-tubulin antibodies were from
ICN Biomedicals. Unless otherwise indicated, all other reagents
were purchased from Sigma-Aldrich.
 
Neutrophil Isolation.
 
Neutrophils were isolated from healthy
volunteers by dextran (3%) sedimentation followed by centrifu-
gation through a discontinuous ficoll gradient. Neutrophil pellets
were resuspended in DMEM supplemented with 10% fetal calf
serum, 1% penicillin/streptomycin solution, and fungizone at a
concentration of 10
 
6 
 
cells/ml. Cells were incubated in polypro-
pylene tubes (Falcon; Becton Dickinson) to prevent adherence.
Neutrophil purity, as assessed by size and granularity on flow cy-
tometry, was consistently 
 
 
 
95%.
 
Quantification of Apoptosis.
 
Spontaneous apoptosis of neutro-
phils was quantified by flow cytometry as the percent of cells with
hypodiploid DNA at 24 h. 10
 
6 
 
cells were centrifuged at 400 
 
g 
 
for
5 min and then gently resuspended in 400 
 
 
 
l hypotonic fluoro-
chrome solution (50 
 
 
 
g/ml propidium iodide, 3.4 mM sodium
citrate, 1 mM Tris, 0.1 mM EDTA, 0.1% Triton X-100 in PBS,
pH 7.2) followed by incubation at 4
 
 
 
C for 10 min. Cells were an-
alyzed (minimum of 5,000 events per sample) using a Coulter
Epics XL-mcl cytofluorimeter and all measurements were per-
formed under the same instrument settings. Apoptotic nuclei
were distinguished from normal nuclei by their hypodiploid
DNA content.
 
Preparation of Cell-free Extracts.
 
Cell-free extracts of primary
human neutrophils were prepared as previously described (14,
24). In brief, 5 
 
  
 
10
 
8 
 
cells (from four to five pooled donors) were
packed into a 2-ml homogenizer and an equal volume of ice cold
cell extract buffer was added (CEB: 20 mM Hepes-KOH, pH
7.5, 10 mM KCl, 1.5 mM MgCl
 
2
 
, 1 mM EDTA, 1 mM EGTA,
1 mM dithiothreitol, 100 
 
 
 
M PMSF, 10 
 
 
 
g/ml leupeptin, 2 
 
 
 
g/
ml aprotinin). Cells were allowed to swell on ice for 20–30 min
in the CEB and then were lysed by homogenization with 
 
 
 
20–
30 strokes of a B-type pestle. Crude extracts were then centri-
fuged for 30 min at 15,000 
 
g
 
 to remove nuclei, unbroken cells,
and other debris. Postnuclear extracts were then used for immu-
nodepletions as described below.
 
Immunodepletion of Extracts.
 
Cell extracts were immunode-
pleted of specific caspases or cytochrome 
 
c 
 
as previously described
(14, 24). In brief, 40 
 
 
 
l of a 50% slurry of protein A/G agarose
beads (Santa Cruz Biotechnology, Inc.) were coated with 5 
 
 
 
g
depletion antibody by continual rotation for 3 h at 4
 
 
 
C in PBS,
pH 7.2 (final volume of 200 
 
 
 
l). Purified rabbit or mouse IgG
(Sigma-Aldrich) was used as a control. Antibody-coated beads
 
*
 
Abbreviations used in this paper:
 
 Apaf-1, apoptotic protease-activating fac-
tor 1; HSP-60, heat shock protein 60; IAP, inhibitor of apoptosis protein;
IP, immunoprecipitation; MnSOD, manganese superoxide dismutase;
Smac, second mitochondrial activator of caspases; XIAP, X-linked inhib-
itor of apoptosis protein.T
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were then washed twice with PBS, pH 7.2, before adding to cell
extracts. 100 
 
 
 
l cell extracts were immunodepleted overnight at
4
 
 
 
C under constant rotation followed by removal of antibody-
coated beads by centrifugation. Depleted extracts were used im-
mediately and were not refrozen.
 
Assembly of Cell-free Reactions.
 
Cell-free reactions were typi-
cally set up in 10–100-
 
 
 
l reaction volumes. For 100-
 
 
 
l scale re-
actions, 50 
 
 
 
l cell extract (
 
 
 
30 mg/ml) was brought to a final
volume of 100 
 
 
 
l in CEB. Caspase activation was initiated by the
addition of 50 
 
 
 
g/ml bovine heart cytochrome 
 
c
 
 and 1 mM
dATP. 10–20 
 
 
 
l samples of cell-free reactions were removed at
various times and frozen at 
 
 
 
70
 
 
 
C for subsequent Western blot
analysis of caspase activation.
 
Preparation of Subcellular Fractions.
 
Cytosolic and mitochon-
drial-enriched fractions of neutrophils and Jurkat cells were
generated using a digitonin-based subcellular fractionation tech-
nique essentially as previously described (23). In brief, 10
 
7 
 
cells
were harvested by centrifugation at 800 
 
g
 
, washed in PBS, pH
7.2, and recentrifuged. Cells were digitonin permeabilized for 5
min on ice at a density of 3 
 
  
 
10
 
7
 
/ml in cytosolic extraction
buffer (250 mM sucrose, 70 mM KCl, 137 mM NaCl, 4.3 mM
Na
 
2
 
HPO
 
4
 
, 1.4 mM KH
 
2
 
PO
 
4
 
, pH 7.2, 100 
 
 
 
M PMSF, 10 
 
 
 
g/
ml leupeptin, 2 
 
 
 
g/ml aprotinin, containing 250 
 
 
 
g/ml digito-
nin). Plasma membrane permeabilization of cells was confirmed
by staining in a 0.2% trypan blue solution. Cells were then cen-
trifuged at 1,000 
 
g
 
 for 5 min at 4
 
 
 
C. The supernatants (cytosolic
fractions) were saved and the pellets solubilized in the same vol-
ume of mitochondrial lysis buffer (50 mM Tris, pH 7.4, 150
mM NaCl, 2 mM EDTA, 2 mM EGTA, 0.2% Triton X-100,
0.3% NP-40, 100 
 
 
 
M PMSF, 10 
 
 
 
g/ml leupeptin, 2 
 
 
 
g/ml
aprotinin) followed by centrifugation at 10,000 
 
g
 
 for 10 min at
4
 
 
 
C. For the detection of MnSOD or cytochrome 
 
c
 
, equal vol-
umes (32 
 
 
 
l) of cytosolic and pellet fractions were supple-
mented with 5
 
  
 
SDS-PAGE loading buffer and subjected to
standard 12% SDS-PAGE.
 
Immunoprecipitation (IP) of Cytochrome c.
 
Cell lysates were pre-
pared by resuspending cells in 800 
 
 
 
l IP lysis buffer (50 mM Tris-
Cl, pH 8.0, 150 mM NaCl, 1% NP-40) containing 100 
 
 
 
M
PMSF, 10 
 
 
 
g/ml leupeptin, and 2 
 
 
 
g/ml aprotinin. After cen-
trifugation, clarified lysates were subjected to IP using 1 
 
 
 
g anti–
cytochrome 
 
c
 
 antibody (BD Biosciences) and 30 
 
 
 
l agarose-cou-
pled protein A/G (Santa Cruz Biotechnology, Inc.). Samples
were incubated under rotation for 3–6 h at 4
 
 
 
C and complexes
were washed three to four times in IP lysis buffer containing 0.1%
NP-40.
 
Immunostaining.
 
Freshly isolated primary human neutrophils
were loaded with Mitotracker CMXRos (Molecular Probes) by
incubation with 50 nM Mitotracker CMXRos for 45 min fol-
lowed by washing. Neutrophils were then cytospun onto glass
slides at a density of 5 
 
  
 
10
 
5 
 
cells/ml followed by immediate fixa-
tion in 3% paraformaldehyde/PBS for 10 min. Fixed cells were
then washed three times in PBS and permeabilized in 0.15% Tri-
ton X-100 in PBS for 15 min. Cells were blocked for 30 min in
2% BSA/PBS and probed with a 1:40 dilution (25 
 
 
 
g/ml final
concentration) of anti–cytochrome 
 
c
 
 (clone 6H2.B4; BD Bio-
sciences) for 2 h at room temperature. After incubation with pri-
mary antibody, cells were washed three times (10 min per wash)
in 2% BSA/PBS followed by probing for 1 h with a 1:500 dilu-
tion (4 
 
 
 
g/ml final concentration) of Alexafluor 488–conjugated
anti–mouse antibodies (Molecular Probes). Immunostained cells
were washed three times in PBS, briefly stained with 20 
 
 
 
M
Hoechst 33358 in PBS, and mounted in Slowfade Light Antifade
mounting medium (Molecular Probes).
 
Results and Discussion
 
Neutrophil Mitochondria Are Deficient in Cytochrome c.
 
Mitochondria have been implicated as important sensors of
cellular damage in diverse cell types. However, previous
reports suggest that neutrophils are incapable of oxidative
phosphorylation, suggesting that these cells contain very
few or defective mitochondria (20). Mitotracker staining
studies indicate that primary neutrophils do contain mito-
chondrial structures (21), which led us to explore whether
these mitochondria contain cytochrome 
 
c
 
 and possess an
intact apoptosome pathway to caspase activation. Initially,
we prepared total cell lysates from primary human neutro-
phils and explored the relative levels of the mitochondrial
proteins: cytochrome 
 
c
 
, cytochrome 
 
c
 
 oxidase (subunit I),
manganese superoxide dismutase (MnSOD), Smac/DI-
ABLO, and HSP-60 in neutrophils versus other cell types.
As controls, we also probed the same cell lysates for cyto-
plasmic proteins. As illustrated in Fig. 1, although neutro-
phils contained readily detectable levels of MnSOD, they
appeared devoid of the other mitochondrial proteins exam-
ined (cytochrome 
 
c
 
, cytochrome 
 
c
 
 oxidase, and HSP-60).
In contrast, caspase-1, -3, -8, and actin were readily detect-
able in the same lysates. Even prolonged overexposure of
the blots failed to detect cytochrome 
 
c
 
 in lysates from neu-
trophils whereas this protein was readily detectable in all
other cells types tested (not depicted).
To explore further whether neutrophil mitochondria
contain cytochrome 
 
c
 
, we prepared concentrated mito-
chondrial and cytosolic fractions from neutrophils using
standard methods. As a control, we prepared similar frac-
Figure 1. Neutrophils are deficient in cytochrome c and other mito-
chondrial proteins. Lysates (107 cells/ml) were prepared from primary hu-
man neutrophils (neutrophils were pooled from five donors) and the indi-
cated cell lines. Equal amounts of protein ( 100  g) were separated by
SDS-PAGE followed by probing replicate blots with antibodies against
the indicated proteins.T
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tions from Jurkat T cells, a cell line that contains relatively
low levels of cytochrome c (Fig. 1). Numerous studies have
shown that cytochrome c enters the cytosol during apopto-
sis initiated by cytotoxic drugs such as staurosporine and ac-
tinomycin D. However, whereas cytochrome c was readily
detectable in the mitochondrial fractions prepared from
staurosporine- or actinomycin D–treated Jurkat cells (Fig. 2
A), mitochondrial cytochrome c failed to be detected in
similar fractions prepared from primary human neutrophils
(Fig. 2 B). MnSOD was readily detected in neutrophil as
well as Jurkat mitochondrial preparations confirming that
these preparations do contain mitochondria.
Neutrophils Retain an Intact Cytochrome c/Apaf-1 Pathway
to Caspase Activation. To date, cytochrome c is the only
protein known to be capable of promoting assembly of the
Apaf-1 apoptosome. Thus, the apparent absence of cyto-
chrome c from neutrophils was provocative and suggested
either that primary human neutrophils do not require cyto-
chrome c for engagement of the apoptosome or that these
cells cannot engage this pathway. To explore these alterna-
tives, we generated cell-free extracts of neutrophils (devoid
of mitochondria) and explored whether these extracts were
capable of supporting caspase activation in response to the
addition of exogenous cytochrome c/dATP. For compara-
tive purposes, we also generated cell-free extracts from Jur-
kat and HEK293 cells which are known to possess an intact
cytochrome c/Apaf-1 pathway.
Because little is known concerning the caspase repertoire
in primary neutrophils, we initially compared the relative
abundance of caspase-1, -2, -3, -4, -6, -7, -8, -9, and -14
in neutrophils versus Jurkat and HE293T cells. As shown in
Fig. 3 A, neutrophils were found to express essentially all of
these caspases with the notable exception of caspase-2. In-
terestingly, highly elevated levels of caspase-1 were also de-
tected in neutrophils, which is consistent with the role of
these cells in inflammatory responses and their ability to
produce mature IL-1 . Previous studies using cell-free ex-
tracts of Jurkat, Hela, and HEK293 cells have shown that
the addition of cytochrome c and dATP to these extracts is
sufficient to trigger assembly of the Apaf-1 apoptosome,
which recruits and activates caspase-9. The latter event has
been shown to propagate a well-defined cascade of caspase
activation events involving caspase-9, -3, -7, -6, -2, -8, and
-10 (Fig. 3 B; reference 14). As illustrated in Fig. 3 B, the
addition of cytochrome c and dATP to neutrophil cell-free
extracts also triggered the processing of a similar repertoire
of caspases (with the exception of caspase-2, which was un-
detectable in neutrophil lysates), suggesting that the Apaf-
1–dependent caspase activation pathway was indeed intact
in these cells.
Neutrophil Cell-free Extracts Do not Require the Addition of
Exogenous Cytochrome c to Initiate Apaf-1–dependent Caspase
Activation. Because our earlier experiments failed to de-
tect cytochrome c in neutrophil mitochondrial prepara-
tions, the possibility remained that neutrophils do not re-
quire cytochrome c to engage the apoptosome pathway to
caspase activation. To explore whether this was the case,
we performed an experiment in which dATP was added to
the extracts over a range of concentrations in the absence
of exogenous cytochrome c. As expected, cell-free extracts
derived from Jurkat or HEK293 cells failed to support
dATP-inducible caspase activation in the absence of exoge-
nously added cytochrome c (Fig. 4 A). Rather surprisingly,
neutrophil cell-free extracts exhibited robust activation of
caspase-3, which did not require the addition of exogenous
cytochrome c, suggesting that these cells might be able to
assemble apoptosomes in the absence of this cofactor (Fig.
4 A). Caspase-3 activation was seen over a wide range of
dATP concentrations but was abolished in the absence of
this nucleotide.
To exclude the possibility that this observation was due
to contamination of neutrophil cell-free extracts by cyto-
chrome c (as a result of mitochondrial rupture) during their
preparation, we assessed the relative levels of cytochrome c
in the extracts by Western blotting. As Fig. 4 B illustrates
and in line with our earlier observations, cytochrome c was
undetectable in neutrophil cell-free extracts but trace
amounts were found in extracts generated from Jurkat and
HEK293 cells. Thus, despite the fact that both Jurkat and
HEK293 cell extracts contained detectable amounts of en-
dogenous cytochrome c, these cell extracts still required the
addition of exogenous cytochrome c for assembly of the ap-
optosome and caspase activation. In contrast, neutrophil
Figure 2. Apoptosis-associated mitochondrial cytochrome c releases in
Jurkat but not neutrophils. (A) Jurkat cells were induced to undergo
apoptosis by treated with 500 nM staurosporine or 20  M actinomycin D
and mitochondrial and cytosolic fractions were prepared at the indicated
times as described in Materials and Methods. Cell fractions were probed
with the indicated antibodies. (B) Primary human neutrophils and Jurkat
cells were treated with 500 nM staurosporine or 20  M actinomycin D
followed by preparation of mitochondrial and cytosolic fractions. Cell
fractions were then probed for cytochrome c and MnSOD as indicated.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
629 Murphy et al.
extracts that appeared devoid of cytochrome c were still ca-
pable of supporting dATP-inducible caspase activation.
To confirm that the dATP-inducible caspase activating
complex in neutrophils was indeed composed of Apaf-1
and caspase-9, we generated cell-free extracts depleted of
both of these constituents. As a control, similar depletions
were performed with Jurkat cell-free extracts. As Fig. 5
shows, although mock-immunodepleted neutrophil ex-
tracts were capable of supporting dATP-inducible caspase-3
activation, extracts depleted of Apaf-1 and caspase-9 were
not, confirming that the dATP-inducible caspase-activating
complex observed in neutrophil cell-free extracts was in-
deed comprised of Apaf-1 and caspase-9.
Immunodepletion of Cytochrome c Arrests dATP-inducible
Caspase Activation. It remained formally possible that neu-
trophil cell-free extracts contained trace amounts of cyto-
chrome c below the detection threshold of direct Western
blot analysis, but sufficient to support dATP-inducible
caspase activation. Although we considered this possibility
unlikely, we performed an immunodepletion experiment
Figure 3. The cytochrome c–ini-
tiated caspase activation cascade is
intact in neutrophils. (A) Cell-free
extracts were prepared from Jurkat,
HEK293, and primary neutrophils as
described in Materials and Methods.
Equal amounts (125  g) of protein
were separated by SDS-PAGE fol-
lowed by probing replicate blots
with antibodies against the indicated
proteins. Note the absence of cas-
pase-2 in neutrophil cell-free ex-
tracts. (B) Kinetics of cytochrome
c/dATP-inducible caspase activation
in Jurkat, HEK293, and neutrophil
cell-free extracts. Cell-free reactions
were assembled as described in Ma-
terials and Methods and incubated at
37 C for the indicated times. Data
are representative of at least four to
five independent experiments.
Figure 4. Neutrophil cell-free extracts contain undetectable amounts of
cytochrome c but support robust dATP-inducible caspase activation. (A)
Jurkat, HEK293, and primary neutrophil cell-free extracts were incubated
in the presence or absence of 50  g/ml cytochrome c along with the indi-
cated amounts of dATP. Reactions were stopped after 60 min followed by
analysis of caspase-3 activation status in the extracts. (B) Equal amounts
(120  g) of protein from Jurkat, HEK293, or neutrophil cell-free extracts
were separated by SDS-PAGE followed by probing for cytochrome c.
Data are representative of at least three independent experiments.
Figure 5. dATP-inducible caspase activation in neutrophil cell-free ex-
tracts is Apaf-1 and caspase-9 dependent. Jurkat and neutrophil cell-free
extracts were immunodepleted of Apaf-1 and caspase-9 as described in
Materials and Methods. Mock-depleted or Apaf-1/caspase-9–depleted
extracts were assessed for their ability to support dATP- or cytochrome
c/dATP-inducible caspase activation by incubation for 2 h at 37 C as in-
dicated (dATP was added to 1 mM and cytochrome c to 50  g/ml final
concentrations). Note that depletion of Apaf-1/caspase-9 completely ab-
rogated dATP-inducible caspase activation in both cases. Data are repre-
sentative of two independent experiments.T
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with anti-cytochrome c antibodies to assess whether this
would abolish Apaf-1–dependent caspase activation in
these extracts. Neutrophil and Jurkat cell-free extracts were
subjected to overnight depletion with anti–cytochrome c
antibodies and were then assessed for their ability to sup-
port dATP-inducible caspase activation. Surprisingly, this
procedure completely abolished dATP-triggered caspase
activation in neutrophil extracts, which was readily restored
by the addition of exogenous cytochrome c (Fig. 6). The
latter result suggested that despite our inability to detect cy-
tochrome c by direct Western blot analysis of neutrophil
cell lysates or mitochondrial fractions, these cells do retain
trace amounts of this mitochondrial protein that remains
necessary for apoptosome assembly.
Neutrophils Contain Trace Amounts of Cytochrome c. In an
effort to detect cytochrome c in neutrophils, we conducted
extensive Western blot analysis of neutrophil lysates in
comparison with lysates prepared from Jurkat and HEK293
cells. Although cytochrome c was readily detectable in ly-
sates prepared from as few as 5   104 Jurkat or HEK293
cells, this protein remained below the detection threshold
in lysates prepared from 5   105 neutrophils (Fig. 7 A). In
contrast, MnSOD was readily detectable in neutrophil ly-
sates and appeared almost as abundant as in Jurkat and
HEK293 cells. In a further effort to detect cytochrome c in
neutrophils, IP analysis was performed. This approach suc-
ceeded in detecting cytochrome c in neutrophils, although
 10 times the number of neutrophils (as compared with
Jurkat or HEK293 cells) were required to saturate the same
amount of antibody used for IP (Fig. 7 B). Thus, it appears
that primary human neutrophils contain a fraction ( 10%)
of the cytochrome c that is contained in the other cell types
examined. Despite this, cytochrome c was still evidently re-
quired for apoptosome assembly in these cells (Fig. 6).
To exclude the possibility that only a minor subset of
neutrophils (or contaminating cells in the neutrophil prepa-
rations) expressed cytochrome c, we also conducted immu-
nofluorescence analysis (Fig. 8). Initially, we incubated pri-
mary neutrophils with Mitotracker Red to assess whether
this dye would become incorporated into mitochondrial
structures as is readily observed in other cell types. As illus-
trated in Fig. 8 A, neutrophils exhibited significant uptake
of Mitotracker dye into punctate cytoplasmic structures as
previously reported (21). Immunostaining of neutrophils
for cytochrome c also resulted in a punctate pattern that
colocalized well with Mitotracker-positive areas of the cell,
confirming that primary neutrophils do indeed contain cy-
tochrome c (Fig. 8 B).
Neutrophil Cell-free Extracts Display a Lowered Threshold for
Cytochrome c–inducible Caspase Activation. Because neutro-
phils contain minimal cytochrome c but can readily support
dATP-inducible caspase activation, this suggested that these
cells may have a lowered threshold requirement for cyto-
chrome c to initiate Apaf-1–dependent caspase activation.
To explore whether this was the case, we used cytochrome
c–depleted neutrophil extracts to determine the minimum
concentration of exogenous cytochrome c required to sup-
port dATP-inducible caspase activation. As a control, cyto-
chrome c–depleted Jurkat and HEK293 extracts were used
for comparison. Using this approach, we found that neu-
trophil cell-free lysates were capable of supporting caspase
activation at cytochrome c concentrations well below
( 5%) those required to achieve caspase activation in Jur-
kat and HEK293 cell-free lysates (Fig. 9).
Neutrophils Contain Elevated Apaf-1 Levels. The low-
ered threshold for cytochrome c–initiated caspase activa-
tion in neutrophils could be due to multiple factors. How-
ever, possible reasons include elevated Apaf-1 levels or
abnormally low levels of molecules that can antagonize
Apaf-1 function such as the inhibitor of apoptosis proteins
Figure 6. dATP-inducible caspase activation in neutrophil cell-free ex-
tracts is cytochrome c dependent. Jurkat and neutrophil cell-free extracts
were immunodepleted of cytochrome c as described in Materials and
Methods. Mock- or cytochrome c–depleted extracts were assessed for
their ability to support dATP- or cytochrome c/dATP-inducible caspase
activation by incubation for 1 h at 37 C as indicated (dATP was added to
1 mM and cytochrome c to 50  g/ml final concentrations). Data are rep-
resentative of three independent experiments.
Figure 7. Relative levels of cytochrome c in primary neutrophils, Jur-
kat, and HEK293 cells. (A) Total protein lysates were prepared from
equal numbers of Jurkat, HEK293, and neutrophils (107 cells/ml). The in-
dicated cell equivalents were loaded on 15% SDS-PAGE gels followed by
Western blot analysis of cytochrome c and MnSOD levels in the lysates.
The indicated amounts of bovine cytochrome c were loaded as a control
and to enable comparisons between different blots. (B) Cytochrome c was
immunoprecipitated from lysates prepared from the indicated numbers of
Jurkat or primary neutrophils. IPs were performed as described in Materi-
als and Methods.T
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(IAPs). To explore these obvious possibilities, we assessed
the relative levels of Apaf-1, XIAP, cIAP-1, survivin, and
Bruce in Jurkat and HEK293 cells and primary neutro-
phils. As Fig. 10 illustrates, this analysis revealed that neu-
trophils possess highly elevated Apaf-1 levels and modest
or undetectable amounts of the IAP proteins relative to the
other cell types examined. One interpretation of these ob-
servations is that the paucity of cytochrome c in neutro-
phils is compensated for by elevated Apaf-1 levels in these
cells. Increased abundance of Apaf-1 may facilitate efficient
apoptosome assembly even in the context of very limiting
amounts of cytochrome c.
The observations reported in this study suggest that neu-
trophils retain an intact apoptosome pathway to caspase ac-
tivation despite possessing mitochondria that are incapable
of significant mitochondrial respiration (20). This pathway
involved a repertoire of caspases similar to that previously
reported in other cell types with the exception of caspase-2,
which was not detected in neutrophil lysates. The absence
of caspase-2 at the mRNA and protein levels in primary
neutrophils has also been previously reported (25). The or-
der of cytochrome c/Apaf-1–initiated caspase activation
events observed in neutrophils (unpublished data) was also
identical to that previously reported for Jurkat cells (14).
Despite difficulties encountered in detecting cytochrome
c in neutrophil lysates by direct Western blot analysis, this
protein was detected by immunofluorescence as well as by
IP analysis and was estimated to be present in neutrophils at
levels that are a fraction ( 10% or less) of those observed in
proliferating cell lines. Because cytochrome c is essential for
electron transport within the mitochondrial respiratory
chain, this observation may at least partly explain why neu-
trophils exhibit almost undetectable rates of mitochondrial
respiration. Nonetheless, these levels of cytochrome c were
both necessary and sufficient to support Apaf-1–dependent
caspase activation in neutrophil cell-free extracts, but not in
HEK293 nor Jurkat cell extracts. This suggests that neutro-
phils have a lowered threshold requirement for cytochrome
c for engagement of the Apaf-1–dependent pathway to
Figure 8. Immunolocalization of
cytochrome  c in primary neutro-
phils. (A) Purified human neutro-
phils were incubated for 45 min at
37 C in Mitotracker Red followed
by fixation and staining with
Hoechst dye to visualize nuclei. (B)
Neutrophils were labeled with Mi-
totracker Red followed by immu-
nostaining for cytochrome c as de-
scribed in Materials and Methods.
Figure 9. Neutrophil cell-free extracts exhibit a lowered threshold for
cytochrome c–triggered caspase activation. Cell-free lysates prepared from
primary neutrophils, Jurkat, or HEK293 cells (adjusted to the same final
protein concentration) were immunodepleted of cytochrome c as de-
scribed in Materials and Methods. The concentration of exogenous cyto-
chrome c required to trigger Apaf-1–dependent caspase activation was
then assessed by incubation of the extracts for 1 h at 37 C in the presence
of 1 mM dATP as indicated.
Figure 10. Neutrophils contain highly
elevated Apaf-1 levels and reduced levels of
IAPs. Lysates (107 cells/ml) were prepared
from primary human neutrophils (neutro-
phils were pooled from five donors) and the
indicated cell lines. (A) Equal amounts of
protein ( 100  g) were separated by SDS-
PAGE followed by probing replicate blots
with antibodies against Apaf-1. Recombi-
nant Apaf-1 was obtained by transiently
overexpressing an Apaf-1 expression plas-
mid in HEK293 cells. (B) Proteins were
loaded as in A and were probed for the indi-
cated IAP proteins.T
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caspase activation, but the reason(s) for this remain unclear.
Factors such as highly elevated Apaf-1 levels and decreased
levels of the caspase inhibitory proteins, XIAP and cIAP1,
may facilitate apoptosome assembly at the low concentra-
tions of cytochrome c that are attainable in neutrophils.
In conclusion, although primary neutrophils contain few
mitochondria that are most likely deficient in electron trans-
port, these mitochondria retain sufficient cytochrome c to
instigate the Apaf-1–dependent pathway to caspase activa-
tion and apoptosis. It remains unclear whether this pathway
is engaged during neutrophil senescence-associated apopto-
sis or whether an alternative pathway to caspase activation is
engaged during neutrophil turnover in vivo. However, be-
cause neutrophils undergo apoptosis in response to many
stimuli that engage the Apaf-1–dependent pathway in other
cell types, it is likely that this pathway represents an impor-
tant physiological route to neutrophil apoptosis.
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